ALHC Документы SEC - Alignment Healthcare, Inc.- Годовой отчет, доверенное заявление, проспект эмиссии

Основная статистика

CIK

1832466

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Alignment Healthcare, Inc.

SEC Filings (Chronological Order)

На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.

July 30, 2025	EX-99.1	Alignment Healthcare Reports Second Quarter 2025 Results; Raises Full-Year Outlook Across All Key Metrics EXHIBIT 99.1 Alignment Healthcare Reports Second Quarter 2025 Results; Raises Full-Year Outlook Across All Key Metrics Reports total revenue of $1.0 billion in Q2 and 223,700 health plan members as of June 30, up 49.0% and 27.8% year-over-year respectively Surpasses high-end of Q2 guidance across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDA Raises full-year outlo
July 30, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
July 30, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Alignment Healthcar UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissio
June 11, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 ALIGNMENT HEALTHCARE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 ALIGNMENT HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commission
May 1, 2025	EX-10.4	Amendment to Amended and Restated Employment Agreement, dated as of April 28, 2025, between Alignment Healthcare USA, LLC and Dawn Maroney Exhibit 10.4 AMENDMENT TO AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDMENT TO AMENDED & RESTATED EMPLOYMENT AGREEMENT (this “Amendment”), effective as of April 28, 2025 (the “Effective Date”), by and between Alignment Healthcare USA, LLC, a California corporation (the “Employer”), and Dawn Maroney (the “Employee”). RECITALS WHEREAS, Company and Employee are parties to that certain Amended &
May 1, 2025	EX-99.1	Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition EXHIBIT 99.1 Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 members Exceeds high-end of Q1 guidance on membership, revenue, adju
May 1, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
May 1, 2025	EX-10.2	Amendment to Amended and Restated Employment Agreement, dated as of Exhibit 10.2 AMENDMENT TO AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDMENT TO AMENDED & RESTATED EMPLOYMENT AGREEMENT (this “Amendment”), effective as of the Effective Date (defined below), by and between Alignment Healthcare USA, LLC, a California corporation (the “Employer”), and Thomas Freeman (the “Employee”). RECITALS WHEREAS, Company and Employee are parties to that certain Amended & R
May 1, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2025 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commission
May 1, 2025	EX-10.1	Employment Agreement, dated as of May 2, 2025, between Alignment Healthcare USA, LLC and James Head Exhibit 10.1 EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND JAMES HEAD May 2, 2025 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made and entered into effective as of May 2, 2025 (the “Effective Date”), by and between Alignment Healthcare USA, LLC, a California corporation (the “Employer”), and James Head (the “Employee”). WHEREAS, the Employer desires to employ the Employee, a
May 1, 2025	EX-10.3	Amendment to Amended and Restated Employment Agreement, dated as of April 28, 2025, between Alignment Healthcare USA, LLC and John Kao Exhibit 10.3 AMENDMENT TO AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDMENT TO AMENDED & RESTATED EMPLOYMENT AGREEMENT (this “Amendment”), effective as of April 28, 2025 (the “Effective Date”), by and between Alignment Healthcare USA, LLC, a California corporation (the “Employer”), and John E. Kao (the “Employee”). RECITALS WHEREAS, Company and Employee are parties to that certain Amended & R
April 25, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
April 25, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
April 15, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2025 ALIGNMENT HEALTHCAR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2025 ALIGNMENT HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissio
April 11, 2025	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2025 ALIGNMENT HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissio
February 27, 2025	EX-21.1	List of Subsidiaries of Alignment Healthcare, Inc. Exhibit 21.1 LIST OF SUBSIDIARIES OF ALIGNMENT HEALTHCARE, INC. Name of Subsidiary Jurisdiction of Incorporation AdvocateMD Holdings, LLC Delaware AdvocateMD Operations, LLC Florida Alignment Health Advisors, LLC Delaware Alignment Health Insurance Company of Arizona, Inc. Arizona Alignment Health Plan (f/k/a Honored Citizens Choice Health Plan, Inc.) California Alignment Health Plan of Arizona, I
February 27, 2025	EX-19	Alignment Healthcare, Inc. Insider Trading Policy Exhibit 19 INSIDER TRADING POLICY Revised as of October 31, 2022 PURPOSE This policy pertains to the disclosure of material non-public information (as defined herein) regarding Alignment Healthcare, Inc.
February 27, 2025	EX-10.13	Employment Agreement of Hakan Kardes dated as of April 11, 2021 Exhibit 10.13 EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND HAKAN KARDES APRIL 11, 2021 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made and entered into effective as of April 11, 2021 (the “Effective Date”), by and between Alignment Healthcare USA, LLC, a California corporation (the “Employer”), and Hakan Kardes (the “Employee”). WHEREAS, the Employer desires to continue to
February 27, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40
February 27, 2025	EX-99.1	Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance EXHIBIT 99.1 Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectations Achieves first full year of positive adjusted EBITDA as a public company, driven by operating leverage and strong medical benefits ratio performance Raises midp
February 27, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commi
February 13, 2025	EX-99.A	Joint Filing Agreement EX-99.A 2 e664197ex99-a.htm Exhibit A Joint Filing Agreement The undersigned agree that this Schedule 13G, and all amendments thereto, relating to the Common Stock of Alignment Healthcare, Inc. shall be filed on behalf of the undersigned. DEERFIELD MGMT, L.P. By: J.E. Flynn Capital, LLC, General Partner By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact DEERFIELD MANAGEMENT COMPANY, L.P. By:
February 13, 2025	EX-99.B	Exhibit B EX-99.B 3 e664197ex99-b.htm Exhibit B Due to the relationships between them, the reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.
January 13, 2025	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2025 ALIGNMENT HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commis
January 13, 2025	EX-99.2	1 Medicare Advantage Done Right A NEW ERA OF AGING © 2025 Alignment Healthcare USA, LLC. All Rights Reserved. Alignment Healthcare is a registered trademark with the U.S. Patent and Trademark Office. 2 Legal Disclaimer Forward Looking Statements This 1 Medicare Advantage Done Right A NEW ERA OF AGING © 2025 Alignment Healthcare USA, LLC.
January 13, 2025	EX-99.1	Alignment Healthcare Announces Industry-Leading Membership Growth and Promotion of Dawn Maroney to President Alignment Healthcare Announces Industry-Leading Membership Growth and Promotion of Dawn Maroney to President •Achieves 35% year-over-year growth to 209,900 members on Jan.
November 25, 2024	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 22, 2024 ALIGNMENT HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commi
November 25, 2024	EX-4.1	ALIGNMENT HEALTHCARE, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 22, 2024 4.25% Convertible Senior Notes due 2029 TABLE OF CONTENTS Execution Version ALIGNMENT HEALTHCARE, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 22, 2024 4.25% Convertible Senior Notes due 2029 TABLE OF CONTENTS Page Section 1.01 . Definitions 1 Section 1.02 . References to Interest 13 ARTICLE 2 Issue, Description, Execution, Registration and Exchange of Notes Section 2.01 . Designation and Amount 13 Sec
November 15, 2024	EX-4.1	ALIGNMENT HEALTHCARE, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 22, 2024 4.25% Convertible Senior Notes due 2029 TABLE OF CONTENTS ALIGNMENT HEALTHCARE, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 22, 2024 4.25% Convertible Senior Notes due 2029 TABLE OF CONTENTS Page Section 1.01 . Definitions 1 Section 1.02 . References to Interest 13 ARTICLE 2 Issue, Description, Execution, Registration and Exchange of Notes Section 2.01 . Designation and Amount 13 Section 2.02 . Form o
November 15, 2024	EX-99.1	Proceeds to be used to lower the Company’s cost of capital by repaying the Company’s existing term loan facility and for general corporate purposes Alignment Healthcare Announces Private Convertible Senior Notes Transaction November 15, 2024 Proceeds to be used to lower the Company’s cost of capital by repaying the Company’s existing term loan facility and for general corporate purposes ORANGE, Calif.
November 15, 2024	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2024 ALIGNMENT HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commi
November 15, 2024	EX-10.1	[Signature Pages Follow] November 14, 2024 Alignment Healthcare, Inc. 1100 W. Town and Country Road, Suite 1600 Orange, California 92868 Attention: Chief Financial Officer Re: Subscription for Alignment Healthcare, Inc. Convertible Senior Notes due 2029 Ladies and Gentlemen: Alignment Healthcare, Inc., a Delaware corporation, (the “Company”), is offering a new series of its Convertible Senior Notes due 2029 (the “Notes”).
November 14, 2024	SC 13G/A	ALHC / Alignment Healthcare, Inc. / Warburg Pincus Private Equity XII, L.P. - SC 13G/A Passive Investment SC 13G/A 1 d896517dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Alignment Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 01625V104 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check th
October 29, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2024 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commis
October 29, 2024	EX-99.1	Alignment Healthcare Reports Third Quarter 2024 Results EXHIBIT 99.1 Alignment Healthcare Reports Third Quarter 2024 Results Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end expectations One of seven Medicare Advantage Prescription Drug contracts nationally to earn 5- out of 5 stars from the Centers for M
October 29, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
August 16, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2024 ALIGNMENT HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commiss
August 16, 2024	EX-10.1	Consulting Agreement by and between Alignment Healthcare USA, LLC and Jeffrey Margolis, dated as of August INDIVIDUAL CONSULTING SERVICES AGREEMENT THIS INDIVIDUAL CONSULTING SERVICES AGREEMENT (this “Agreement”) is made and entered into as of August 13, 2024 (“Effective Date”), by and between Alignment Healthcare USA, LLC, a Delaware Limited Liability Company (the “Company”) and Jeffrey H.
August 1, 2024	EX-99.1	Alignment Healthcare Reports Second Quarter 2024 Results EXHIBIT 99.1 Alignment Healthcare Reports Second Quarter 2024 Results Reports $681.3 million in total revenue, up 47.3% year-over-year Records strong Medicare Advantage membership growth, up 56.1% year-over-year to approximately 175,100 members, beating expectations Increases year-end membership and revenue guidance, and maintains full-year adjusted gross profit and adjusted EBITDA guidance ORANGE
August 1, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2024 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissi
August 1, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
June 14, 2024	8-K	Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2024 ALIGNMENT HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissio
June 13, 2024	EX-3.1	Certificate of Amendment to Amended and Restated Certificate of Incorporation of Alignment Healthcare, Inc. (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K filed on June 13, 2024). CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ALIGNMENT HEALTHCARE, INC.
June 13, 2024	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2024 ALIGNMENT HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commission
June 6, 2024	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2024 ALIGNMENT HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commission
June 6, 2024	EX-99.1	1 A NEW ERA OF AGING Alignment Health USA, LLC Confidential and Proprietary Information Copyright Alignment Health USA, LLC 2024 All Rights Reserved \| Unauthorized Use Prohibited William Blair 44th Annual Growth Stock Conference 2 Legal Disclaimer Fo 1 A NEW ERA OF AGING Alignment Health USA, LLC Confidential and Proprietary Information Copyright Alignment Health USA, LLC 2024 All Rights Reserved \| Unauthorized Use Prohibited William Blair 44th Annual Growth Stock Conference 2 Legal Disclaimer Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended.
May 17, 2024	SC 13G	ALHC / Alignment Healthcare, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
May 2, 2024	EX-99.1	Alignment Healthcare Reports First Quarter 2024 Results EXHIBIT 99.1 Alignment Healthcare Reports First Quarter 2024 Results Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% year-over-year respectively Medicare Advantage membership grows 50.5% year-over-year to approximately 165,100 members Increases membership and revenue outlook following strong first-quarter enrollment results, narrows yea
May 2, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
May 2, 2024	EX-10.1	, 2024, among Alignment Healthcare, Inc. and the other signatories party thereto. Exhibit 10.1 AMENDED AND RESTATED STOCKHOLDERS AGREEMENT THIS AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”) is made and entered into as of April 30, 2024, by and among Alignment Healthcare, Inc., a Delaware corporation (the “Company”), General Atlantic (ALN HLTH), LP, a Delaware limited partnership (together with its affiliated investment entities, the “GA Stockholder”), and Warbu
May 2, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2024 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commission
April 26, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Sta
April 26, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
April 12, 2024	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Sta
February 27, 2024	EX-21.1	List of Subsidiaries of Alignment Healthcare, Inc. Exhibit 21.1 LIST OF SUBSIDIARIES OF ALIGNMENT HEALTHCARE, INC. Name of Subsidiary Jurisdiction of Incorporation AdvocateMD Holdings, LLC Delaware AdvocateMD Operations, LLC Florida Alignment Health Advisors, LLC Delaware Alignment Health Insurance Company of Arizona, Inc. Arizona Alignment Health Plan (f/k/a Honored Citizens Choice Health Plan, Inc.) California Alignment Health Plan of Arizona, I
February 27, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2024 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commi
February 27, 2024	EX-99.1	Alignment Healthcare Reports Fourth Quarter and Full-Year 2023 Results; Provides Full-Year 2024 Financial Guidance EXHIBIT 99.1 Alignment Healthcare Reports Fourth Quarter and Full-Year 2023 Results; Provides Full-Year 2024 Financial Guidance Reports $1.82 billion in total revenue for full-year 2023 and 119,200 health plan members at year end, up 27.2% and 21.1% year-over-year respectively Records strong health plan membership growth after annual enrollment period, up 44% year-over-year as of Jan. 1 Reiterates
February 27, 2024	EX-3.2	Amended and Restated Bylaws of Alignment Healthcare, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Form 10-K filed on February 27, 2024). Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ALIGNMENT HEALTHCARE, INC. A Delaware corporation (Adopted as of February 22, 2024) Alignment Healthcare, Inc. (the “Corporation”), pursuant to the provisions of Section 109 of the General Corporation Law of the State of Delaware (the “DGCL”), hereby adopts these Amended and Restated Bylaws (these “Bylaws”), which restate, amend and supersede the bylaws o
February 27, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ta UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40295 ALIGNMENT H
February 27, 2024	EX-97	Alignment Healthcare, Inc. Clawback Policy Exhibit 97 ALIGNMENT HEALTHCARE, INC. CLAWBACK POLICY Alignment Healthcare, Inc. (the “Company”) has adopted this Policy in accordance with the listing requirements of the Nasdaq Stock Exchange (the “Exchange”) and Rule 10D and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (“Rule 10D”) to provide for the recovery of erroneously awarded Incentive-based Compensation from Executive Of
January 8, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commiss
January 8, 2024	EX-99.1	Legal Disclaimer Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the DELIVERING A BREAKTHROUGH YEAR A NEW ERA OF AGING © 2024 Alignment Healthcare USA, LLC.
December 29, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2023 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commi
December 29, 2023	EX-10.1	Amendment to Employment Agreement of Joseph Konowiecki dated December 27. 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on December 29, 2023) Exhibit 10.1 AMENDMENT TO EMPLOYMENT AGREEMENT This AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is entered into by and between Alignment Healthcare USA, LLC (the “Employer”) and Joseph Konowiecki (the “Employee”) as of this 27th day of December 2023. WHEREAS, Employer and Employee are parties to that certain Employment Agreement dated as of October 31, 2022 (the “Original Agreement”), pur
November 2, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q premium UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
November 2, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2023 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commis
November 2, 2023	EX-10.3	Separation Agreement and General Release, dated as of July 13, 2023, between Alignment Healthcare USA, LLC and Richard Cross. Exhibit 10.3 CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE This Confidential Separation Agreement and General Release (“Agreement”), dated July 13, 2023 (the “Execution Date”), is made by and between Richard Cross (“Employee”), on the one hand, and Alignment Healthcare USA, LLC (“Alignment” or the “Company”), on the other hand. The parties to this Agreement may be referred to singularly as
November 2, 2023	EX-99.1	Alignment Healthcare Reports Third Quarter 2023 Results; Exceeds Guidance Across All Key Financial Metrics EXHIBIT 99.1 Alignment Healthcare Reports Third Quarter 2023 Results; Exceeds Guidance Across All Key Financial Metrics Reports $456.7 million in total revenue, up 26.7% year-over-year Medicare Advantage enrollment increases to approximately 115,600 members, up 18% year-over-year Outperforms on four key performance indicators: membership, revenue, adjusted gross profit and adjusted EBITDA Raises y
September 15, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 14, 2023 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Comm
September 15, 2023	EX-10.1	Form of Performance Share Unit Award Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on September 15, 2023). Exhibit 10.1 PSU AWARD AGREEMENT ALIGNMENT HEALTHCARE, INC. 2021 EQUITY INCENTIVE PLAN Alignment Healthcare, Inc. (the “Company”) grants to the Participant named below (“you”) the number of restricted stock units that are subject to Performance Goals and designated as Performance Awards (“PSUs”) set forth below (the “Award”), under this PSU Award Agreement (“Agreement”). Governing Plan: Alignment
September 6, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2023 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commi
September 6, 2023	EX-10.1	Employment Agreement between the Company and Hyong (Ken) Kim, M.D., dated as of September 25, 2023 Exhibit 10.1 EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND HYONG (KEN) KIM, M.D. September 25, 2023 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made and entered into effective as of September 25, 2023 (the “Effective Date”), by and between Alignment Healthcare USA, LLC, a California corporation (the “Employer”), and Hyong (Ken) Kim, M.D. (the “Employee”). WHEREAS, the Employ
August 15, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissi
August 15, 2023	EX-10.1	Confidential Separation Agreement and General Release by Dinesh Kumar (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on August 15, 2023). Exhibit 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (“Agreement”), dated August 9, 2023 (the “Execution Date”), is made by and between Dinesh Kumar (“Employee”), on the one hand, and Alignment Healthcare USA, LLC (“Alignment” or the “Company”), on the other hand. The parties to this Agreement may be referred to singularly as a “Party” or collectively
August 3, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q premium UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
August 3, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2023 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissi
August 3, 2023	EX-99.1	Alignment Healthcare Reports Second Quarter 2023 Results; Beats Outlook Across All Four Critical KPIs EXHIBIT 99.1 Alignment Healthcare Reports Second Quarter 2023 Results; Beats Outlook Across All Four Critical KPIs Reports $462.4 million in total revenue, up 26.2% year-over-year Medicare Advantage enrollment increases to approximately 112,200 members, up 17% year-over-year ORANGE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) - Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantag
July 14, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2023 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissio
June 9, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2023 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commission
May 4, 2023	EX-99.1	Alignment Healthcare Reports Strong First Quarter 2023 Results; Exceeds Outlook Across All Four Critical KPIs EXHIBIT 99.1 Alignment Healthcare Reports Strong First Quarter 2023 Results; Exceeds Outlook Across All Four Critical KPIs Reports $439.2 million in total revenue, up 27.1% year-over-year Medicare Advantage enrollment increases to approximately 109,700 members Delivers consistent performance underpinned by strong care management capabilities and stable utilization trends ORANGE, Calif., May 04, 20
May 4, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Alignment Healthcare, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commission
May 4, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q premium UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
April 27, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
April 26, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
February 28, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40295 ALIGNMENT HEAL
February 28, 2023	EX-10	Amended & Restated Employment Agreement of Richard Cross dated March 26, 2021 Exhibit 10.12 EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND RICHARD CROSS MARCH 26, 2021 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made and entered into effective as of March 26, 2021 (the “Effective Date”), by and between Alignment Healthcare USA, LLC, a California corporation (the “Employer”), and Richard Cross (the “Employee”). WHEREAS, the Employer desires to continue
February 28, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 Alignment Healt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commi
February 28, 2023	EX-21	List of Subsidiaries of Alignment Healthcare, Inc. Exhibit 21.1 LIST OF SUBSIDIARIES OF ALIGNMENT HEALTHCARE, INC. Name of Subsidiary Jurisdiction of Incorporation AdvocateMD Holdings, LLC Delaware AdvocateMD Operations, LLC Florida Alignment Health Advisors, LLC Delaware Alignment Health Insurance Company of Arizona, Inc. Arizona Alignment Health Plan (f/k/a Honored Citizens Choice Health Plan, Inc.) California Alignment Health Plan of Arizona, I
February 28, 2023	EX-10	Amendment No. 1 to Term Loan Agreement and Amendment No. 1 to Security Agreement dated January 30, 2023 (incorporated by reference to Exhibit 10.3 to the Company's Form 10-K filed on February 28, 2023). Exhibit 10.3 AMENDMENT NO. 1 TO TERM LOAN AGREEMENT AND AMENDMENT NO. 1 TO SECURITY AGREEMENT THIS AMENDMENT NO. 1 TO TERM LOAN AGREEMENT AND AMENDMENT NO. 1 TO SECURITY AGREEMENT, dated as of January 30, 2023 (this “Amendment”), is made among ALIGNMENT HEALTHCARE, INC., a Delaware corporation (“Parent”), ALIGNMENT HEALTHCARE HOLDCO 1, LLC, a Delaware limited liability company (“Healthcare Holdco”
February 28, 2023	EX-99.1	Alignment Healthcare Reports Fourth Quarter and Full-Year 2022 Results; Provides Full-Year 2023 Financial Guidance EXHIBIT 99.1 Alignment Healthcare Reports Fourth Quarter and Full-Year 2022 Results; Provides Full-Year 2023 Financial Guidance Reports $1.43 billion in total revenue for 2022, up 23% year-over-year Beats high end of fourth quarter and full-year guidance on revenue, adjusted gross profit and adjusted EBITDA Demonstrates replicability of the company's clinical management capabilities outside its co
February 13, 2023	SC 13G/A	ALHC / Alignment Healthcare, Inc. / GENERAL ATLANTIC LLC - AMENDMENT NO. 1 Passive Investment SC 13G/A 1 eh23032929913ga1-alignment.htm AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Alignment Healthcare, Inc. (Name of Issuer) Class A common stock, par value $0.001 per share (Title of Class of Securities) 01625V104 (CUSIP Number) December 31, 2022 (Date of Event Which Requires
February 10, 2023	SC 13G/A	ALHC / Alignment Healthcare, Inc. / Warburg Pincus Private Equity XII, L.P. - SC 13G/A Passive Investment SC 13G/A 1 d429262dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Alignment Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 01625V104 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the
January 9, 2023	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2023 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commiss
November 3, 2022	EX-10.1	Term Loan Agreement, dated as of September 2, 2022, by and among Alignment Healthcare, Inc., Alignment Healthcare USA, LLC, as borrower, certain other subsidiaries of the Company, the lenders from time to time party thereto and Oxford Finance LLC, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 to the Company’s Form 10-Q filed on November 3, 2022) Exhibit 10.1 Term Loan Agreement dated as of September 2, 2022 among Alignment Healthcare, Inc., as Parent, Alignment Healthcare Holdco 1, LLC, as Healthcare Holdco, Alignment Healthcare Holdco 2, LLC, as Holdings, Alignment Healthcare USA, LLC, as Borrower, the Guarantors from time to time party hereto, the Lenders from time to time party hereto and Oxford Finance LLC, as Administrative Agent and
November 3, 2022	EX-10.2	Security Agreement, dated as of September 2, 2022, by and among Alignment Healthcare USA, the other grantors from time to time party thereto and Oxford Finance LLC, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.2 to the Company’s Form 10-Q filed on November 3, 2022). Exhibit 10.2 ??????????????????????????????????????????????????????? SECURITY AGREEMENT dated as of September 2, 2022 among ALIGNMENT HEALTHCARE USA, LLC, the other Grantors from time to time party hereto and OXFORD FINANCE LLC, as Administrative Agent and Collateral Agent ?????????????????????????????????????????????????????? Table of Contents (continued) Page Table of Contents Page Section 1. De
November 3, 2022	EX-10.3	Employment Agreement of Joseph Konowiecki dated October 31, 2022 (incorporated by reference to Exhibit 10.3 to the Company’s Form 10-Q filed on November 3, 2022) Exhibit 10.3 EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND JOSEPH KONOWIECKI OCTOBER 31, 2022 1 Doc#: US1:14577886v2 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made and entered into effective as of October 31, 2022 (the ?Effective Date?), by and between Alignment Healthcare USA, LLC, a California corporation (the ?Employer?), and Joseph Konowiecki (the ?Employee?). WHEREAS,
November 3, 2022	EX-99.1	Alignment Healthcare Reports Third Quarter Results; Continues to Beat Guidance Across All Key Financial Metrics; Raises Full-Year 2022 Outlook EXHIBIT 99.1 Alignment Healthcare Reports Third Quarter Results; Continues to Beat Guidance Across All Key Financial Metrics; Raises Full-Year 2022 Outlook Reports $360.3 million in total revenue, up 22.8% year-over-year Exceeds high end of guidance on four key performance indicators: membership, revenue, adjusted gross profit and adjusted EBITDA Earns high performance and quality ratings from Cen
November 3, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2022 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commis
November 3, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q premium UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
September 20, 2022	EX-1.1	Underwriting Agreement, dated as of September 15, 2022, by and among the Company, the Selling Stockholders and J.P. Morgan Securities LLC. EX-1.1 2 d378769dex11.htm EX-1.1 Exhibit 1.1 Alignment Healthcare, Inc. 9,000,000 Shares of Common Stock, $0.001 par value Underwriting Agreement September 15, 2022 J.P. Morgan Securities LLC As representative (the “Representatives”) of the several Underwriters named in Schedule I hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Ladies and Gentlemen: Certain stockh
September 20, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 Or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2022 Alignment Healthcare, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Comm
September 19, 2022	EX-FILING FEES	Calculation of Filing Fee Tables (Form Type) Alignment Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Exhibit 107 Calculation of Filing Fee Tables 424(b)(7) (Form Type) Alignment Healthcare, Inc.
September 19, 2022	424B7	9,000,000 Shares Alignment Healthcare COMMON STOCK 424B7 1 d388799d424b7.htm 424B7 Table of Contents Filed Pursuant to Rule 424(b)(7) Registration No. 333-267438 Prospectus supplement (To prospectus dated September 15, 2022) 9,000,000 Shares Alignment Healthcare COMMON STOCK The selling stockholders identified in this prospectus supplement are offering 9,000,000 shares of our common stock. We are not selling any shares under this prospectus supple
September 15, 2022	EX-4.1	Form of Indenture (if debt securities are offered by a supplement to this Registration Statement, the Registrant will file with the Commission a trustee’s Statement of Eligibility on Form T-1). Exhibit 4.1 ALIGNMENT HEALTHCARE, INC. and [ ], Trustee FORM OF INDENTURE Dated as of [ ] Providing for Issuance of Securities in Series Table Showing Reflection in Indenture of Certain Provisions of Trust Indenture Act of 1939, as amended by the Trust Indenture Reform Act of 1990 Reflected in Indenture TIA Section ?SS?310 (a)(1) 6.09 (a)(2) 6.09 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5)
September 15, 2022	424B7	Subject to completion, dated September 15, 2022 424B7 1 d388799d424b7.htm 424B7 Table of Contents Filed Pursuant to Rule 424(b)(7) Registration No. 333-267438 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell, and we are not soliciting an offer to buy, these securities in any jurisdiction where the offer or
September 15, 2022	S-3ASR	Powers of attorney related to the Company (included in signature page). Table of Contents As filed with the Securities and Exchange Commission on September 15, 2022 Registration No.
September 15, 2022	EX-FILING FEES	Filing Fee Table. Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Alignment Healthcare, Inc.
September 6, 2022	8-K	Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2022 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commi
August 4, 2022	EX-99.1	Alignment Healthcare Reports Second Quarter Results; Exceeds Guidance Across All Key Financial Metrics; Raises Full-Year 2022 Outlook EXHIBIT 99.1 Alignment Healthcare Reports Second Quarter Results; Exceeds Guidance Across All Key Financial Metrics; Raises Full-Year 2022 Outlook Reports $366.5 million in total revenue, up 18.6% year-over-year Adjusted gross profit exceeds guidance for fifth consecutive quarter since IPO, leading to company's lowest medical benefits ratio recorded in a quarter as a public company Continues to br
August 4, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2022 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissi
August 4, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q premium UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
August 3, 2022	8-K/A	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2022 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incor
June 15, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2022 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissio
May 5, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2022 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commission
May 5, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q premium UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
May 5, 2022	EX-99.1	Alignment Healthcare Reports First Quarter 2022 Financial Results; Beats Guidance Across Four Key KPIs; Continues Sustainable Growth EXHIBIT 99.1 Alignment Healthcare Reports First Quarter 2022 Financial Results; Beats Guidance Across Four Key KPIs; Continues Sustainable Growth Reports $345.5 million in total revenue, up 29.4% year-over-year, led by 25.0% growth in health plan premium revenue of $330.9 million Secures 13.4% membership growth year over year, beating high end of Q1 membership guidance Gross margin engine produces
May 5, 2022	EX-10.1	Confidential Separation Agreement and General Release Exhibit 10.1 CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE This Confidential Separation Agreement and General Release (“Agreement”), dated March 23, 2022 (the “Execution Date”), is made by and between Rajesh Shrestha (“Employee”), on the one hand, and Alignment Healthcare USA, LLC (“Alignment” or the “Company”), on the other hand. The parties to this Agreement may be referred to singularly
April 28, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEF 14A 1 def14aproxystatement.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by
April 28, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEFA14A 1 defa14a-notice2022.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by R
April 7, 2022	144	OMB APPROVAL 144 1 d235449d144.htm 144 OMB APPROVAL OMB Number: 3235-0101 Expires: July 31, 2023 Estimated average burden hours per response ....... 1.0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 SEC USE ONLY DOCUMENT SEQUENCE NO. CUSIP NUMBER WORK LOCATION ATTENTION: Transmit for f
April 4, 2022	144	OMB APPROVAL 144 1 d235449d144.htm 144 OMB APPROVAL OMB Number: 3235-0101 Expires: July 31, 2023 Estimated average burden hours per response 1.0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 SEC USE ONLY DOCUMENT SEQUENCE NO. CUSIP NUMBER WORK LOCATION ATTENTION: Transmit for filing
April 4, 2022	144	OMB APPROVAL OMB APPROVAL OMB Number: 3235-0101 Expires: July 31, 2023 Estimated average burden hours per response 1.
April 4, 2022	144	OMB APPROVAL OMB APPROVAL OMB Number: 3235-0101 Expires: July 31, 2023 Estimated average burden hours per response 1.
April 4, 2022	144	OMB APPROVAL 144 1 d235449d144.htm 144 OMB APPROVAL OMB Number: 3235-0101 Expires: July 31, 2023 Estimated average burden hours per response 1.0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 SEC USE ONLY DOCUMENT SEQUENCE NO. CUSIP NUMBER WORK LOCATION ATTENTION: Transmit for filing 3
April 4, 2022	144	OMB APPROVAL 144 1 d235449d144.htm 144 OMB APPROVAL OMB Number 3235-0101 Expires: July 31, 2023 Estimated average burden hours per response 1.0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 SEC USE ONLY DOCUMENT SEQUENCE NO. CUSIP NUMBER WORK LOCATION ATTENTION: Transmit for filing 3 c
April 4, 2022	144	OMB APPROVAL 144 1 d235449d144.htm 144 OMB APPROVAL OMB Number: 3235-0101 Expires: July 31, 2023 Estimated average burden hours per response 1.0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 SEC USE ONLY DOCUMENT SEQUENCE NO. CUSIP NUMBER WORK LOCATION ATTENTION: Transmit for filing 3
April 4, 2022	144	OMB APPROVAL 144 1 d235449d144.htm 144 OMB APPROVAL OMB Number: 3235-0101 Expires: July 31, 2023 Estimated average burden hours per response 1.0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 SEC USE ONLY DOCUMENT SEQUENCE NO. CUSIP NUMBER WORK LOCATION ATTENTION: Transmit for filing 3
March 25, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2022 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissi
March 3, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2022 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissio
March 3, 2022	EX-10.12	Amended & Restated Employment Agreement of Rajesh Shrestha Exhibit 10.12 AMENDED & RESTATED EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND RAJESH SHRESTHA MARCH 26, 2021 AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDED & RESTATED EMPLOYMENT AGREEMENT is made and entered into by and between Alignment Healthcare USA, LLC, a California corporation (the ?Employer?), and Rajesh Shrestha (the ?Employee?) and will become effective on March 26
March 3, 2022	EX-99.1	Alignment Healthcare Reports Fourth Quarter and Full-Year 2021 Financial Results EXHIBIT 99.1 Alignment Healthcare Reports Fourth Quarter and Full-Year 2021 Financial Results ORANGE, Calif., March 03, 2022 (GLOBE NEWSWIRE) - Alignment Healthcare, Inc. (?Alignment Healthcare? or the ?Company?) (Nasdaq: ALHC), a tech-enabled Medicare Advantage company, today reported financial results for its fourth quarter and full year ended Dec. 31, 2021. ?Our strong fourth-quarter results ac
March 3, 2022	EX-4.2	Description of Capital Stock (incorporated by reference to Exhibit 4.2 to the Company’s Form 10-K filed on March 3, 2022). Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK General Our authorized capital stock consists of 1,000,000,000 shares of common stock, par value $0.001 per share, and 100,000,000 shares of undesignated preferred stock, par value $0.001 per share. As of the February 28, 2022, we had 187,067,046 shares of our common stock outstanding. The following description of our capital stock is intended as a summary
March 3, 2022	EX-10.13	Amended & Restated Employment Agreement of Dinesh Kumar dated March 26, 2021 (incorporated by reference to Exhibit 10.13 to the Company’s Form 10-K filed on March 3, 2022) Exhibit 10.13 AMENDED & RESTATED EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND DINESH KUMAR MARCH 26, 2021 AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDED & RESTATED EMPLOYMENT AGREEMENT is made and entered into effective as of March 26, 2021 (the ?Effective Date?), by and between Alignment Healthcare USA, LLC, a California corporation (the ?Employer?), and Dinesh Kumar (the
March 3, 2022	EX-21.1	List of Subsidiaries of Alignment Healthcare, Inc. Exhibit 21.1 LIST OF SUBSIDIARIES OF ALIGNMENT HEALTHCARE, INC. Name of Subsidiary Jurisdiction of Incorporation Alignment Health Advisors, LLC Delaware Alignment Health Insurance Company of Arizona, Inc. Arizona Alignment Health Plan (f/k/a Honored Citizens Choice Health Plan, Inc.) California Alignment Health Plan of Arizona, Inc. Arizona Alignment Health Plan of Nevada, Inc. Nevada Alignment He
March 3, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40295 ALIGNMENT HEAL
March 1, 2022	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2021 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Com
February 14, 2022	SC 13G	ALHC / Alignment Healthcare, Inc. / Warburg Pincus Private Equity XII, L.P. - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Alignment Healthcare, Inc. (Name of Issuer) Class A common stock, par value $0.001 per share (Title of Class of Securities) 01625V104 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to des
February 11, 2022	SC 13G	ALHC / Alignment Healthcare, Inc. / GENERAL ATLANTIC LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Alignment Healthcare, Inc. (Name of Issuer) Class A common stock, par value $0.001 per share (Title of Class of Securities) 01625V104 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des
January 10, 2022	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2022 Alignment Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commis
December 27, 2021	EX-99.1	Alignment Healthcare Appoints Jody Bilney and Yon Yoon Jorden to its Board of Directors EXHIBIT 99.1 Alignment Healthcare Appoints Jody Bilney and Yon Yoon Jorden to its Board of Directors ORANGE, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) - Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced the appointment of Jody Bilney and Yon Yoon Jorden to its Board of Directors, effective Jan. 1, 2022. ?We are delighted to welcome Jody and Yon to the boa
December 27, 2021	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2021 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commi
November 19, 2021	424B4	8,000,000 Shares Alignment Healthcare COMMON STOCK Table of Contents Filed pursuant to Rule 424(b)(4) Registration Statement No. 333-261113 8,000,000 Shares Alignment Healthcare COMMON STOCK The selling stockholders identified in this prospectus are offering an aggregate of 8,000,000 shares of our common stock. We are not selling any shares under this prospectus and will not receive any proceeds from the sale of shares by the selling stockholders.
November 16, 2021	EX-1.1	Form of Underwriting Agreement Exhibit 1.1 Alignment Healthcare, Inc. [•] Shares of Common Stock, $0.001 par value — Underwriting Agreement November [•], 2021 Goldman Sachs & Co. LLC Morgan Stanley & Co. LLC As representatives (the “Representatives”) of the several Underwriters named in Schedule I hereto, c/o Goldman Sachs & Co. LLC 200 West Street, New York, New York 10282-2198 c/o Morgan Stanley & Co. LLC 1585 Broadway, New Y
November 16, 2021	S-1	As filed with the Securities and Exchange Commission on November 16, 2021 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Alignment Healthcare, Inc. (Ex Table of Contents As filed with the Securities and Exchange Commission on November 16, 2021 No.
November 16, 2021	CORRESP	ALIGNMENT HEALTHCARE, INC. November 16, 2021 ALIGNMENT HEALTHCARE, INC. November 16, 2021 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-1090 Attention: Jessica Livingston Re: Alignment Healthcare, Inc. Registration Statement on Form S-1 Originally Filed November 16, 2021 CIK: 0001832466 Ladies and Gentlemen: Alignment Healthcare, Inc., a Delaware corporation (the “Company”), hereby reque
November 16, 2021	CORRESP	* * * [Signature Page Follows] November 16, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.
November 4, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2021 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commis
November 4, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q premium UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
November 4, 2021	EX-99.1	Alignment Healthcare Reports Third Quarter 2021 Financial Results EXHIBIT 99.1 Alignment Healthcare Reports Third Quarter 2021 Financial Results ORANGE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) - Alignment Healthcare, Inc. (?Alignment Healthcare? or the ?Company?) (Nasdaq: ALHC), a mission-based, tech-enabled Medicare Advantage company, today reported financial results for its third quarter ended September 30, 2021. ?I?m pleased to be reporting another strong quar
August 9, 2021	EX-99.1	Alignment Healthcare Reports Second Quarter 2021 Financial Results EXHIBIT 99.1 Alignment Healthcare Reports Second Quarter 2021 Financial Results ORANGE, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) - Alignment Healthcare, Inc. (?Alignment Healthcare? or the ?Company?) (Nasdaq: ALHC), a mission-based, tech-enabled Medicare Advantage company, today reported financial results for its second quarter ended June 30, 2021. ?Our results in the second quarter exceeded our exp
August 9, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2021 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or Other Jurisdiction of Incorporation) (Commissi
August 9, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
July 1, 2021	DRS	Confidential Treatment Requested by Alignment Healthcare, Inc. Pursuant to 17 C.F.R. Section 200.83 As submitted confidentially to the Securities and Exchange Commission on June 30, 2021 pursuant to the Jumpstart Our Business Startups Act of 2012. Th Table of Contents Confidential Treatment Requested by Alignment Healthcare, Inc. Pursuant to 17 C.F.R. Section 200.83 As submitted confidentially to the Securities and Exchange Commission on June 30, 2021 pursuant to the Jumpstart Our Business Startups Act of 2012. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein r
May 17, 2021	EX-10.10	Amended & Restated Employment Agreement of Dawn Maroney dated March 26, 2021 (incorporated by reference to Exhibit 10.10 to the Company's Form 10-Q filed on May 17, 2021) Exhibit 10.10 AMENDED & RESTATED EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND DAWN MARONEY MARCH 26, 2021 AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDED & RESTATED EMPLOYMENT AGREEMENT is made and entered into as of March 26, 2021, by and between Alignment Healthcare USA, LLC, a California corporation (the ?Employer?), and Dawn Maroney (the ?Employee?). WHEREAS, the Employe
May 17, 2021	EX-10.11	Amended & Restated Employment Agreement of Thomas Freeman dated March 26, 2021 (incorporated by reference to Exhibit 10.11 to the Company's Form 10-Q filed on May 17, 2021) Exhibit 10.11 AMENDED & RESTATED EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND THOMAS FREEMAN MARCH 26, 2021 AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDED & RESTATED EMPLOYMENT AGREEMENT is made and entered into effective as of March 26, 2021 (the ?Effective Date?), by and between Alignment Healthcare USA, LLC, a California corporation (the ?Employer?), and Thomas Freeman (
May 17, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2021 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40295 46-5596242 (State or other jurisdiction of incorporation) (Commission
May 17, 2021	EX-99.1	ALIGNMENT HEALTHCARE REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS Exhibit 99.1 ALIGNMENT HEALTHCARE REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS ORANGE, Calif. (May 17, 2021) ? Alignment Healthcare, Inc. (?Alignment Healthcare? or the ?Company?) (Nasdaq: ALHC), a mission-based, tech-enabled Medicare Advantage company, today reported financial results for its first quarter ended March 31, 2021. ?I?m incredibly proud of all Alignment Healthcare has accomplished in
May 17, 2021	EX-10.9	Amended & Restated Employment Agreement of John E. Kao dated March 26, 2021 (incorporated by reference to Exhibit 10.9 to the Company's Form 10-Q filed on May 17, 2021) Exhibit 10.9 AMENDED & RESTATED EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND JOHN E. KAO MARCH 26, 2021 AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDED & RESTATED EMPLOYMENT AGREEMENT is made and entered into as of March 26, 2021, by and between Alignment Healthcare USA, LLC, a California corporation (the ?Employer?), and John E. Kao (the ?Employee?). WHEREAS, the Employer d
May 17, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC.
March 31, 2021	S-8	- S-8 As filed with the Securities and Exchange Commission on March 30, 2021 Registration No.
March 31, 2021	EX-99.1	Additional Financial Data Exhibit 99.1 Additional Financial Data We historically operated as a Delaware limited liability company under the name Alignment Healthcare Holdings, LLC. On March 17, 2021, Alignment Healthcare Holdings, LLC converted to a Delaware corporation pursuant to a statutory conversion and we changed our name to Alignment Healthcare, Inc. On March 24, 2021, the board of directors of Alignment Healthcare,
March 30, 2021	EX-3.2	Amended and Restated Bylaws of Alignment Healthcare, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Form 8-K filed on March 30, 2021). Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ALIGNMENT HEALTHCARE, INC. A Delaware corporation (Adopted as of March 25, 2021) Alignment Healthcare, Inc. (the ?Corporation?), pursuant to the provisions of Section 109 of the General Corporation Law of the State of Delaware (the ?DGCL?), hereby adopts these Amended and Restated Bylaws (these ?Bylaws?), which restate, amend and supersede the bylaws of t
March 30, 2021	EX-10.3	Stockholders Agreement, dated as of March 30, 2021, among Alignment Healthcare, Inc. and the other signatories party thereto (incorporated by reference to Exhibit 10.3 to the Company’s Form 8-K filed on March 30, 2021). Exhibit 10.3 STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this ?Agreement?) is made and entered into as of March 30, 2021, by and among Alignment Healthcare, Inc., a Delaware corporation (the ?Company?), General Atlantic (ALN HLTH), LP, a Delaware limited partnership (together with its affiliated investment entities, the ?GA Stockholder?), and Warburg Pincus Private Equity XII, L.P., a Dela
March 30, 2021	EX-99.1	### EX-99.1 Exhibit 99.1 ALIGNMENT HEALTHCARE ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING ORANGE, Calif. (March 30, 2021) – Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a mission-based, tech-enabled Medicare Advantage company, today announced the closing of its initial public offering of 27,200,000 shares of its common stock at $18.00 per share, including 5,500
March 30, 2021	EX-1.1	Underwriting Agreement, dated as of March 25, 2021, among Alignment Healthcare, Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, as representatives of the underwriters named therein, and the Selling Stockholders. EX-1.1 2 d292883dex11.htm EX-1.1 Exhibit 1.1 Alignment Healthcare, Inc. 27,200,000 Shares of Common Stock, $0.001 par value Underwriting Agreement March 25, 2021 Goldman Sachs & Co. LLC Morgan Stanley & Co. LLC As representatives (the “Representatives”) of the several Underwriters named in Schedule I hereto, c/o Goldman Sachs & Co. LLC 200 West Street, New York, New York 10282-2198 c/o Morgan Stan
March 30, 2021	EX-3.1	Amended and Restated Certificate of Incorporation of Alignment Healthcare, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on March 30, 2021). Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ALIGNMENT HEALTHCARE, INC. * * * * * John Kao, being the Chief Executive Officer of Alignment Healthcare, Inc., a corporation duly organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?Corporation?), DOES HEREBY CERTIFY as follows: FIRST: The Corporation was incorporated under the na
March 30, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2021 Alignment Healthcare, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-40295 46-5596242 (State of Incorporation) (Commission File Number) (I.R.S
March 30, 2021	EX-4.1	Registration Rights Agreement, dated as of March 30, 2021, among Alignment Healthcare, Inc. and the other signatories party thereto (incorporated by reference to Exhibit 4.1 to the Company’s Form 8-K filed on March 30, 2021). Exhibit 4.1 ALIGNMENT HEALTHCARE, INC. REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?) is made as of March 30, 2020 among Alignment Healthcare, Inc., a Delaware corporation (the ?Company?), General Atlantic (ALN HLTH), L.P., a Delaware limited partnership, and its Affiliates (as defined herein) (collectively, ?General Atlantic?), Warburg Pincus (as defined herei
March 30, 2021	EX-10.2	Alignment Healthcare, Inc. 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed on March 30, 2021). Exhibit 10.2 ALIGNMENT HEALTHCARE, INC. 2021 EQUITY INCENTIVE PLAN ARTICLE I PURPOSE; EFFECTIVE DATE; TERM 1.1 Purpose. The purpose of the Alignment Healthcare, Inc. 2021 Equity Incentive Plan is to promote the long-term success of the Company and the creation of Stockholder value by (a) encouraging Eligible Employees, Non-Employee Directors and Consultants to focus on the Company?s performance, (
March 29, 2021	424B4	27,200,000 Shares Alignment Healthcare COMMON STOCK Table of Contents Filed pursuant to Rule 424(b)(4) Registration Statement No. 333-253824 27,200,000 Shares Alignment Healthcare COMMON STOCK This is an initial public offering of Alignment Healthcare, Inc. We are selling 21,700,000 shares of our common stock. Certain selling stockholders identified in this prospectus are selling an additional 5,500,000 shares of our common stock. Prior to this off
March 26, 2021	8-A12B	Form 8-A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Alignment Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 46-5596242 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.) 1100 W. Tow
March 23, 2021	CORRESP	Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 March 23, 2021 Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 March 23, 2021 VIA EDGAR Ms.
March 23, 2021	EX-10.19	Form of Option Award Agreement (Senior Executives) (incorporated by reference to Exhibit 10.19 to the Company’s Form S-1 filed on March 23, 2021). Exhibit 10.19 OPTION AWARD AGREEMENT ALIGNMENT HEALTHCARE, INC. 2021 EQUITY INCENTIVE PLAN Alignment Healthcare, Inc. (the “Company”) grants to the Participant named below (“you”) [an Incentive/a Nonstatutory] Stock Option to purchase the number of Shares set forth below (the “Option”), under this Option Award Agreement (“Agreement”). Governing Plan: Alignment Healthcare, Inc. 2021 Equity Incentiv
March 23, 2021	EX-10.20	Form of RSU Award Agreement (Senior Executives) (incorporated by reference to Exhibit 10.20 to the Company’s Form S-1 filed on March 23, 2021). EX-10.20 13 d50030dex1020.htm EX-10.20 Exhibit 10.20 RSU AWARD AGREEMENT ALIGNMENT HEALTHCARE, INC. 2021 EQUITY INCENTIVE PLAN Alignment Healthcare, Inc. (the “Company”) grants to the Participant named below (“you”) the number of restricted stock units (“RSUs”) set forth below (the “Award”), under this RSU Award Agreement (“Agreement”). Governing Plan: Alignment Healthcare, Inc. 2021 Equity Incent
March 23, 2021	EX-10.15	Form of Stockholders Agreement Exhibit 10.15 STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this ?Agreement?) is made and entered into as of March , 2021, by and among Alignment Healthcare, Inc., a Delaware corporation (the ?Company?), General Atlantic (ALN HLTH), LP, a Delaware limited partnership (together with its affiliated investment entities, the ?GA Stockholder?), and Warburg Pincus Private Equity XII, L.P., a Delaw
March 23, 2021	CORRESP	* * * [Signature Page Follows] March 23, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.
March 23, 2021	EX-3.1	Form of Amended and Restated Certificate of Incorporation of Alignment Healthcare, Inc. EX-3.1 3 d50030dex31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ALIGNMENT HEALTHCARE, INC. * * * * * [•], being the [•] of Alignment Healthcare, Inc., a corporation duly organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY as follows: FIRST: The Corporation was incorporated under
March 23, 2021	S-1/A	Form S-1 Table of Contents As filed with the Securities and Exchange Commission on March 23, 2021.
March 23, 2021	EX-10.17	Form of Restricted Shares Award Agreement (incorporated by reference to Exhibit 10.17 to the Company’s Form S-1 filed on March 23, 2021). EX-10.17 10 d50030dex1017.htm EX-10.17 Exhibit 10.17 RESTRICTED SHARES AWARD AGREEMENT ALIGNMENT HEALTHCARE, INC. 2021 EQUITY INCENTIVE PLAN Alignment Healthcare, Inc. (the “Company”) grants to the Participant named below (“you”) the number of Restricted Shares set forth below (the “Award”), under this Restricted Shares Award Agreement (“Agreement”). Governing Plan: Alignment Healthcare, Inc. 2021
March 23, 2021	EX-10.18	Form of RSU Award Agreement (incorporated by reference to Exhibit 10.18 to the Company’s Form S-1 filed on March 23, 2021). EX-10.18 11 d50030dex1018.htm EX-10.18 Exhibit 10.18 RSU AWARD AGREEMENT ALIGNMENT HEALTHCARE, INC. 2021 EQUITY INCENTIVE PLAN Alignment Healthcare, Inc. (the “Company”) grants to the Participant named below (“you”) the number of restricted stock units (“RSUs”) set forth below (the “Award”), under this RSU Award Agreement (“Agreement”). Governing Plan: Alignment Healthcare, Inc. 2021 Equity Incent
March 23, 2021	CORRESP	ALIGNMENT HEALTHCARE, INC. March 23, 2021 ALIGNMENT HEALTHCARE, INC. March 23, 2021 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-1090 Attention: Sonia Bednarowski Rolf Sundwall Sharon Blume Justin Dobbie Re: Alignment Healthcare, Inc. Registration Statement on Form S-1 Originally Filed March 3, 2021 CIK: CIK0001832466 Ladies and Gentlemen: Alignment Healthcare, Inc., a Delaware corpo
March 23, 2021	EX-10.16	Form of Option Award Agreement (incorporated by reference to Exhibit 10.16 to the Company’s Form S-1 filed on March 23, 2021). EX-10.16 9 d50030dex1016.htm EX-10.16 Exhibit 10.16 OPTION AWARD AGREEMENT ALIGNMENT HEALTHCARE, INC. 2021 EQUITY INCENTIVE PLAN Alignment Healthcare, Inc. (the “Company”) grants to the Participant named below (“you”) [an Incentive/a Nonstatutory] Stock Option to purchase the number of Shares set forth below (the “Option”), under this Option Award Agreement (“Agreement”). Governing Plan: Alignment
March 23, 2021	EX-4.1	Form of Registration Rights Agreement EX-4.1 5 d50030dex41.htm EX-4.1 Exhibit 4.1 ALIGNMENT HEALTHCARE, INC. REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of March [•], 2020 among Alignment Healthcare, Inc., a Delaware corporation (the “Company”), General Atlantic (ALN HLTH), L.P., a Delaware limited partnership, and its Affiliates (as defined herein) (collectively, “General Atlantic”),
March 23, 2021	EX-1.1	Form of Underwriting Agreement Exhibit 1.1 Alignment Healthcare, Inc. [?] Shares of Common Stock, $0.001 par value Underwriting Agreement [?], 2021 Goldman Sachs & Co. LLC Morgan Stanley & Co. LLC As representatives (the ?Representatives?) of the several Underwriters named in Schedule I hereto, c/o Goldman Sachs & Co. LLC 200 West Street, New York, New York 10282-2198 c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New Yor
March 23, 2021	EX-3.2	Form of Amended and Restated Bylaws of Alignment Healthcare, Inc. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ALIGNMENT HEALTHCARE, INC. A Delaware corporation (Adopted as of [•], 2021) Alignment Healthcare, Inc. (the “Corporation”), pursuant to the provisions of Section 109 of the General Corporation Law of the State of Delaware (the “DGCL”), hereby adopts these Amended and Restated Bylaws (these “Bylaws”), which restate, amend and supersede the bylaws of the Co
March 23, 2021	EX-10.6	Form of Director and Officer Indemnification Agreement (incorporated by reference to Exhibit 10.6 to the Company’s Form S-1 filed on March 23, 2021). Exhibit 10.6 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this ?Agreement?) is made and entered into as of [ ], 2021 between Alignment Healthcare, Inc., a Delaware corporation (the ?Company?), and [ ] (?Indemnitee?). WHEREAS, highly competent persons have become more reluctant to serve corporations as directors or officers or in other capacities unless they are provided with adequate
March 18, 2021	EX-10.8	Form of 2021 Equity Incentive Plan Exhibit 10.8 ALIGNMENT HEALTHCARE, INC. 2021 EQUITY INCENTIVE PLAN ARTICLE I PURPOSE; EFFECTIVE DATE; TERM 1.1 Purpose. The purpose of the Alignment Healthcare, Inc. 2021 Equity Incentive Plan is to promote the long-term success of the Company and the creation of Stockholder value by (a) encouraging Eligible Employees, Non-Employee Directors and Consultants to focus on the Company’s performance, (
March 18, 2021	EX-10.11	Form of Employment Agreement of Thomas Freeman EX-10.11 5 d50030dex1011.htm EX-10.11 Exhibit 10.11 AMENDED & RESTATED EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND THOMAS FREEMAN MARCH 26, 2021 AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDED & RESTATED EMPLOYMENT AGREEMENT is made and entered into effective as of March 26, 2021 (the “Effective Date”), by and between Alignment Healthcare USA, LLC, a California corporation
March 18, 2021	S-1/A	- S-1/A Table of Contents As filed with the Securities and Exchange Commission on March 18, 2021.
March 18, 2021	EX-10.9	Form of Employment Agreement of John E. Kao Exhibit 10.9 AMENDED & RESTATED EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND JOHN E. KAO MARCH 26, 2021 AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDED & RESTATED EMPLOYMENT AGREEMENT is made and entered into as of March 26, 2021, by and between Alignment Healthcare USA, LLC, a California corporation (the “Employer”), and John E. Kao (the “Employee”). WHEREAS, the Employer d
March 18, 2021	EX-10.10	Form of Employment Agreement of Dawn Maroney Exhibit 10.10 AMENDED & RESTATED EMPLOYMENT AGREEMENT BETWEEN ALIGNMENT HEALTHCARE USA, LLC AND DAWN MARONEY MARCH 26, 2021 AMENDED & RESTATED EMPLOYMENT AGREEMENT THIS AMENDED & RESTATED EMPLOYMENT AGREEMENT is made and entered into as of March 26, 2021, by and between Alignment Healthcare USA, LLC, a California corporation (the “Employer”), and Dawn Maroney (the “Employee”). WHEREAS, the Employe
March 17, 2021	CORRESP	Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 March 17, 2021 CORRESP 1 filename1.htm FOIA Confidential Treatment Request Pursuant to Rule 83 by Alignment Healthcare, Inc. Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 March 17, 2021 Via EDGAR Submission Ms. Sonia Bednarowski Mr. Rolf Sundwall Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re
March 12, 2021	CORRESP	Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 March 12, 2021 FOIA Confidential Treatment Request Pursuant to Rule 83 by Alignment Healthcare, Inc.
March 3, 2021	EX-10.3	Amendment No. 1 to Loan Agreement and Amendment to Fee Letter, dated as of April 25, 2019, among Alignment Healthcare Holdco 2, LLC, Alignment Healthcare USA, LLC as borrower, certain subsidiaries of Alignment Healthcare Holdco 2, LLC as guarantors, the parties named therein as guarantors and lenders and CRG Servicing LLC, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.3 to the Company’s Form S-1 filed on March 3, 2021). Exhibit 10.3 EXECUTION VERSION AMENDMENT NO. 1 TO LOAN AGREEMENT AND AMENDMENT TO FEE LETTER THIS AMENDMENT NO. 1 TO LOAN AGREEMENT AND AMENDMENT TO FEE LETTER, dated as of April 25, 2019 (this “Amendment”), is made among ALIGNMENT HEALTHCARE HOLDCO 2, LLC, a Delaware limited liability company (“Holdings”), ALIGNMENT HEALTHCARE USA, LLC, a Delaware limited liability company (“Borrower”), the Subsi
March 3, 2021	EX-21.1	Subsidiaries of Alignment Healthcare, Inc. Exhibit 21.1 LIST OF SUBSIDIARIES OF ALIGNMENT HEALTHCARE, INC. Name of Subsidiary Jurisdiction of Incorporation Alignment Health Advisors, LLC Delaware Alignment Health Insurance Company of Arizona, Inc. Arizona Alignment Health Plan (f/k/a Honored Citizens Choice Health Plan, Inc.) California Alignment Health Plan of Arizona, Inc. Arizona Alignment Health Plan of Colorado, Inc. Colorado Alignmen
March 3, 2021	EX-10.5	Amendment No. 3 to Loan Agreement and Amendment to Fee Letter, dated as of September 8, 2020, among Alignment Healthcare Holdco 2, LLC, Alignment Healthcare USA, LLC as borrower, certain subsidiaries of Alignment Healthcare Holdco 2, LLC as guarantors, the parties named therein as guarantors and lenders and CRG Servicing LLC, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.5 to the Company’s Form S-1 filed on March 3, 2021). EX-10.5 6 d50030dex105.htm EX-10.5 Exhibit 10.5 EXECUTION VERSION AMENDMENT NO. 3 TO LOAN AGREEMENT THIS AMENDMENT NO. 3 TO LOAN AGREEMENT, dated as of September 8, 2020 (this “Amendment”), is made among ALIGNMENT HEALTHCARE HOLDCO 2, LLC, a Delaware limited liability company (“Holdings”), ALIGNMENT HEALTHCARE USA, LLC, a Delaware limited liability company (“Borrower”), the Subsidiary Guarantors f
March 3, 2021	EX-10.4	Amendment No. 2 to Loan Agreement and Amendment to Fee Letter, dated as of May 26, 2020, among Alignment Healthcare Holdco 2, LLC, Alignment Healthcare USA, LLC as borrower, certain subsidiaries of Alignment Healthcare Holdco 2, LLC as guarantors, the parties named therein as guarantors and lenders and CRG Servicing LLC, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.4 to the Company’s Form S-1 filed on March 3, 2021). EX-10.4 5 d50030dex104.htm EX-10.4 Exhibit 10.4 EXECUTION VERSION AMENDMENT NO. 2 TO LOAN AGREEMENT THIS AMENDMENT NO. 2 TO LOAN AGREEMENT, dated as of May 26, 2020 (this “Amendment”), is made among ALIGNMENT HEALTHCARE HOLDCO 2, LLC, a Delaware limited liability company (“Holdings”), ALIGNMENT HEALTHCARE USA, LLC, a Delaware limited liability company (“Borrower”), the Subsidiary Guarantors from t
March 3, 2021	S-1	Registration Statement - S-1 Table of Contents As filed with the Securities and Exchange Commission on March 3, 2021.
March 3, 2021	EX-10.2	Security Agreement dated as of August 21, 2018 among, among Alignment Healthcare Holdco 2, LLC, Alignment Healthcare USA, LLC as borrower, certain subsidiaries of Alignment Healthcare Holdco 2, LLC as grantors, and CRG Servicing LLC, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.2 to the Company’s Form S-1 filed on March 3, 2021). Exhibit 10.2 EXECUTION VERSION SECURITY AGREEMENT dated as of August 21, 2018 among ALIGNMENT HEALTHCARE USA, LLC, the other Grantors from time to time party hereto and CRG SERVICING LLC, as Administrative Agent and Collateral Agent Table of Contents Page Section 1. Definitions, Etc 2 1.01 Certain Uniform Commercial Code Terms 2 1.02 Additional Definitions 2 1.03 Other Defined Terms 4 Section 2. R
March 3, 2021	EX-10.7	Alignment Healthcare Holdings, LLC Stock Appreciation Rights Plan (incorporated by reference to Exhibit 10.7 to the Company’s Form S-1 filed on March 3, 2021). Exhibit 10.7 FINAL VERSION ALIGNMENT HEALTHCARE HOLDINGS, LLC STOCK APPRECIATION RIGHTS PLAN December 15, 2014 What?s the Stock Appreciation Rights Plan all about? You have received, or you? II soon be receiving, a personalized award letter under the Alignment Healthcare Holdings, LLC Stock Appreciation Rights Plan (as amended and restated from time to time, the ?Plan?). The Plan was adopted by Al
March 3, 2021	EX-10.14	Form of CMS Agreement (incorporated by reference to Exhibit 10.14 to the Company’s Form S-1 filed on March 3, 2021). Exhibit 10.14 CONTRACT WITH ELIGIBLE MEDICARE ADVANTAGE (MA) ORGANIZATION PURSUANT TO SECTIONS 1851 THROUGH 1859 OF THE SOCIAL SECURITY ACT FOR THE OPERATION OF A MEDICARE ADVANTAGE COORDINATED CARE PLAN(S) CONTRACT ( ) Between Centers for Medicare & Medicaid Services (hereinafter referred to as CMS) and [NAME OF HEALTH PLAN] (hereinafter referred to as the MA Organization) CMS and the MA Organiza
March 3, 2021	EX-10.1	Term Loan Agreement, dated as of August 21, 2018, among Alignment Healthcare Holdco 2, LLC, Alignment Healthcare USA, LLC as borrower, certain subsidiaries of Alignment Healthcare Holdco 2, LLC as guarantors, the parties named therein as guarantors and lenders, and CRG Servicing LLC, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 to the Company’s Form S-1 filed on March 3, 2021). EX-10.1 2 d50030dex101.htm EX-10.1 Exhibit 10.1 EXECUTION VERSION TERM LOAN AGREEMENT dated as of August 21, 2018 among ALIGNMENT HEALTHCARE HOLDCO 2, LLC, as Holdings, ALIGNMENT HEALTHCARE USA, LLC, as Borrower, the Guarantors from time to time party hereto, the Lenders from time to time party hereto and CRG SERVICING LLC, as Administrative Agent and Collateral Agent U.S. $100,000,000 Table of Co
February 9, 2021	DRS/A	- Table of Contents Amendment No. 2 to confidential draft submission As confidentially submitted to the Securities and Exchange Commission on February 8, 2021. This draft registration statement has not been publicly filed with the Securities and Exchange Commission, and all information herein remains strictly confidential. No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20
February 8, 2021	DRSLTR	Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 February 8, 2021 Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 February 8, 2021 VIA EDGAR AND FEDERAL EXPRESS Ms.
January 11, 2021	EX-21.1	LIST OF SUBSIDIARIES ALIGNMENT HEALTHCARE, INC. Name of Subsidiary Jurisdiction of Incorporation Alignment Health Advisors, LLC Delaware Alignment Health Insurance Company of Arizona, Inc. Arizona Alignment Health Plan (f/k/a Honored Citizens Choice Exhibit 21.1 LIST OF SUBSIDIARIES OF ALIGNMENT HEALTHCARE, INC. Name of Subsidiary Jurisdiction of Incorporation Alignment Health Advisors, LLC Delaware Alignment Health Insurance Company of Arizona, Inc. Arizona Alignment Health Plan (f/k/a Honored Citizens Choice Health Plan, Inc.) California Alignment Health Plan of Arizona, Inc. Arizona Alignment Health Plan of Colorado, Inc. Colorado Alignmen
January 11, 2021	EX-10.14	CONTRACT WITH ELIGIBLE MEDICARE ADVANTAGE (MA) ORGANIZATION PURSUANT TO SECTIONS 1851 THROUGH 1859 OF THE SOCIAL SECURITY ACT FOR THE OPERATION OF A MEDICARE ADVANTAGE COORDINATED CARE PLAN(S) CONTRACT ( ) Centers for Medicare & Medicaid Services (he EX-10.14 2 filename2.htm Exhibit 10.14 CONTRACT WITH ELIGIBLE MEDICARE ADVANTAGE (MA) ORGANIZATION PURSUANT TO SECTIONS 1851 THROUGH 1859 OF THE SOCIAL SECURITY ACT FOR THE OPERATION OF A MEDICARE ADVANTAGE COORDINATED CARE PLAN(S) CONTRACT ( ) Between Centers for Medicare & Medicaid Services (hereinafter referred to as CMS) and [NAME OF HEALTH PLAN] (hereinafter referred to as the MA Organization
January 11, 2021	DRS/A	- Table of Contents Amendment No. 1 to confidential draft submission As confidentially submitted to the Securities and Exchange Commission on January 11, 2021. This draft registration statement has not been publicly filed with the Securities and Exchange Commission, and all information herein remains strictly confidential. No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20
January 11, 2021	DRSLTR	Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 January 11, 2021 Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 January 11, 2021 VIA EDGAR AND FEDERAL EXPRESS Ms.
December 4, 2020	EX-10.7	ALIGNMENT HEALTHCARE HOLDINGS, LLC STOCK APPRECIATION RIGHTS PLAN December 15, 2014 What’s the Stock Appreciation Rights Plan all about? You have received, or you’ II soon be receiving, a personalized award letter under the Alignment Healthcare Holdi Exhibit 10.7 FINAL VERSION ALIGNMENT HEALTHCARE HOLDINGS, LLC STOCK APPRECIATION RIGHTS PLAN December 15, 2014 What?s the Stock Appreciation Rights Plan all about? You have received, or you? II soon be receiving, a personalized award letter under the Alignment Healthcare Holdings, LLC Stock Appreciation Rights Plan (as amended and restated from time to time, the ?Plan?). The Plan was adopted by Al
December 4, 2020	DRS	- Table of Contents As confidentially submitted to the Securities and Exchange Commission on December 3, 2020.
December 4, 2020	EX-10.3	AMENDMENT NO. 1 TO LOAN AGREEMENT AND AMENDMENT TO FEE LETTER EX-10.3 4 filename4.htm Exhibit 10.3 EXECUTION VERSION AMENDMENT NO. 1 TO LOAN AGREEMENT AND AMENDMENT TO FEE LETTER THIS AMENDMENT NO. 1 TO LOAN AGREEMENT AND AMENDMENT TO FEE LETTER, dated as of April 25, 2019 (this “Amendment”), is made among ALIGNMENT HEALTHCARE HOLDCO 2, LLC, a Delaware limited liability company (“Holdings”), ALIGNMENT HEALTHCARE USA, LLC, a Delaware limited liability company
December 4, 2020	EX-10.1	TERM LOAN AGREEMENT dated as of August 21, 2018 ALIGNMENT HEALTHCARE HOLDCO 2, LLC, as Holdings, ALIGNMENT HEALTHCARE USA, LLC, as Borrower, the Guarantors from time to time party hereto, the Lenders from time to time party hereto CRG SERVICING LLC, Exhibit 10.1 EXECUTION VERSION TERM LOAN AGREEMENT dated as of August 21, 2018 among ALIGNMENT HEALTHCARE HOLDCO 2, LLC, as Holdings, ALIGNMENT HEALTHCARE USA, LLC, as Borrower, the Guarantors from time to time party hereto, the Lenders from time to time party hereto and CRG SERVICING LLC, as Administrative Agent and Collateral Agent U.S. $100,000,000 Table of Contents Page SECTION 1 DEFINITIONS 1
December 4, 2020	EX-10.2	SECURITY AGREEMENT dated as of August 21, 2018 ALIGNMENT HEALTHCARE USA, LLC, the other Grantors from time to time party hereto CRG SERVICING LLC, as Administrative Agent and Collateral Agent Exhibit 10.2 EXECUTION VERSION SECURITY AGREEMENT dated as of August 21, 2018 among ALIGNMENT HEALTHCARE USA, LLC, the other Grantors from time to time party hereto and CRG SERVICING LLC, as Administrative Agent and Collateral Agent Table of Contents Page Section 1. Definitions, Etc 2 1.01 Certain Uniform Commercial Code Terms 2 1.02 Additional Definitions 2 1.03 Other Defined Terms 4 Section 2. R
December 4, 2020	EX-10.4	AMENDMENT NO. 2 TO LOAN AGREEMENT Exhibit 10.4 EXECUTION VERSION AMENDMENT NO. 2 TO LOAN AGREEMENT THIS AMENDMENT NO. 2 TO LOAN AGREEMENT, dated as of May 26, 2020 (this ?Amendment?), is made among ALIGNMENT HEALTHCARE HOLDCO 2, LLC, a Delaware limited liability company (?Holdings?), ALIGNMENT HEALTHCARE USA, LLC, a Delaware limited liability company (?Borrower?), the Subsidiary Guarantors from time to time party thereto (together
December 4, 2020	EX-10.5	AMENDMENT NO. 3 TO LOAN AGREEMENT Exhibit 10.5 EXECUTION VERSION AMENDMENT NO. 3 TO LOAN AGREEMENT THIS AMENDMENT NO. 3 TO LOAN AGREEMENT, dated as of September 8, 2020 (this ?Amendment?), is made among ALIGNMENT HEALTHCARE HOLDCO 2, LLC, a Delaware limited liability company (?Holdings?), ALIGNMENT HEALTHCARE USA, LLC, a Delaware limited liability company (?Borrower?), the Subsidiary Guarantors from time to time party thereto (tog

ALHC / Alignment Healthcare, Inc. - Документы SEC, Годовой отчет, Доверенное заявление

Основная статистика

SEC Filings

SEC Filings (Chronological Order)